TAMPA, Fla., June 28, 2021 (SEND2PRESS NEWSWIRE) — In the new book, “Managing a C. difficile Infection: For Patients, Families, and Caregivers” (ISBN: 979-8519789851), Nancy C. Caralla, three-time C. diff. Survivor, Founding President of the C Diff Foundation, and Karen F. Factor, MS, RD. LDN, Nutrition Wellness Chairperson, share their knowledge and experience with patients, […]
VENTURA, Calif. /California Newswire/ — Dr. Sabine Hazan, founder of ProgenaBiome, a genetic sequencing lab in California, achieved rapid improvement in Alzheimer’s disease (AD) symptoms in an 82-year-old male patient following fecal microbiota transplantation (FMT). Originally published on CaliforniaNewswire.com — ProgenaBiome Announces Alzheimer’s Patient Recalls Daughter’s Birthday After Undergoing Fecal Transplant
VENTURA, Calif., Oct. 7, 2020 (SEND2PRESS NEWSWIRE) — Dr. Sabine Hazan, founder of ProgenaBiome, a genetic sequencing lab in California, achieved rapid improvement in Alzheimer’s disease (AD) symptoms in an 82-year-old male patient following fecal microbiota transplantation (FMT).
ST. LOUIS, Mo., July 11, 2019 (SEND2PRESS NEWSWIRE) — The C Diff Foundation is honored to welcome 30+ international leading topic experts from hospitals, pharma, biotech, academia, and Government agencies to deliver and discuss critical information on global healthcare-associated issues.
